Platforms often have infinite possibilities. How do you choose the best possible indication or products?
Navigo Proteins retained Novateur’s expert to evaluate its platform and advise on the best possible Target Product Profiles in the areas of Ophthalmology, Oncology and Metabolic Diseases. Within 8 weeks the Novateur team developed detailed competitive analysis of each space, and given the opportunities of target areas and strengths of Navigo’s platform provided several Target Product Profiles of “Concept Products” in oncology, ophthalmology and metabolic diseases.